FriedLF, BernardiniJ, JohnstonJR, PirainoB. Peritonitis influences mortality in peritoneal dialysis patients. J Am Soc Nephrol1996; 7:2176–82.
2.
KorbetSM, VoneshEF, FiranekCA. Peritonitis in an urban peritoneal dialysis program: an analysis of infecting pathogens. Am J Kidney Dis1995; 26:47–53.
3.
BunkeCM, BrierME, GolperTA. Outcomes of single organism peritonitis in peritoneal dialysis: gram negatives versus gram positives in the Network 9 Peritonitis Study. Kidney Int1997; 52:524–9.
4.
TroidleL, Gorban–BrennanN, KligerLPN, FinkelsteinF. Differing outcomes of gram-positive and gram-negative peritonitis. Am J Kidney Dis1998; 32:623–8.
5.
ZelenitskyS, BarnsL, FindlayI, AlfaM, ArianoR, FineA. Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998. Am J Kidney Dis2000; 36:1009–13.
6.
Canadian CAPD Clinical Trials Group. Peritonitis in continuous peritoneal dialysis (CAPD): a multi-centre randomized clinical trial comparing the Y connector disinfectant system to standard systems. Perit Dial Int1989; 9:159–63.
7.
HolleyJL, BernardiniJ, PirainoB. Infecting organisms in continuous ambulatory peritoneal dialysis patients on the Y-set. Am J Kidney Dis1994; 23:569–73.
8.
ScheinburgFB, SeligmanAM, FineJ. Transmural migration of intestinal bacteria: study based on the use of radioactive Escherichia coli. N Engl J Med1950; 242:747–51.
